NasdaqGM:PAHCPharmaceuticals
Insider Sale Tests Market View Of Phibro’s Growth And Valuation
BFI Co., LLC, an entity controlled by Phibro Animal Health’s CEO, recently executed a major insider share sale under a pre arranged trading plan.
The transaction followed record beating operating results at NasdaqGM:PAHC, alongside rapid expansion in the company’s vaccine portfolio and international business.
Phibro is also progressing on integration of recent acquisitions that focus on vaccines and related animal health solutions.
Phibro Animal Health, listed as NasdaqGM:PAHC, focuses on...